Trial Profile
A pilot phase II study of estradiol [TX-004HR] in postmenopausal women with vulvar and vaginal atrophy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2018
Price :
$35
*
At a glance
- Drugs Estradiol (Primary)
- Indications Atrophic vaginitis
- Focus Therapeutic Use
- 06 Oct 2018 Results assessing the physical characteristics of TX-004HR in this study, two phase 1 studies and an in-vitro study, presented at the North American Menopause Society 2018 Annual Meeting
- 22 Sep 2016 According to a TherapeuticsMD media release, data of this trial will be presented at annual meetings of the International Menopause Society (IMS) and the North American Menopause Society (NAMS), 2016.
- 09 Mar 2015 Results published in TherapeuticsMD media release.